Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry
暂无分享,去创建一个
E. Tolosa | K. Marder | A. Mirelman | Nir Giladi | D. Berg | T. Foroud | A. Brice | S. Lesage | S. Bressman | J. Corvol | Yuanjia Wang | R. Saunders-Pullman | K. Brockmann | E. Mondragón | J. Ruiz‐Martinez | S. Goldwurm | C. Marras | R. Asselta | C. Siri | G. Mangone | B. Schüle | R. Alcalay | Taneera Ghate | D. Vilas | C. Pont‐Sunyer | H. Mejia‐Santana | F. Kausar | Annie J. Lee | Claustre Pont‐Sunyer
[1] K. Marder,et al. Estimation of genetic risk function with covariates in the presence of missing genotypes , 2017, Statistics in medicine.
[2] E. Tolosa,et al. Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.
[3] D. Zeng,et al. Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data. , 2015, Biometrika.
[4] K. Marder,et al. Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium , 2015, Neurology.
[5] N. Jetté,et al. The prevalence of Parkinson's disease: A systematic review and meta‐analysis , 2014, Movement disorders : official journal of the Movement Disorder Society.
[6] J. Trinh,et al. A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism , 2014, Neurobiology of Aging.
[7] P. Mazzoni,et al. Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations , 2013, Movement disorders : official journal of the Movement Disorder Society.
[8] Ellen Sidransky,et al. The link between the GBA gene and parkinsonism , 2012, The Lancet Neurology.
[9] A. Singleton,et al. The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.
[10] C. Magnani,et al. Kin‐cohort analysis of LRRK2‐G2019S penetrance in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[11] Geert Molenberghs,et al. Random Effects Models for Longitudinal Data , 2010 .
[12] E. Tolosa,et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.
[13] P. Matthews,et al. LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study , 2008, The Lancet Neurology.
[14] Nir Giladi,et al. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease , 2007, Neurology.
[15] K. Marder,et al. Pooled analysis of tobacco use and risk of Parkinson disease. , 2007, Archives of neurology.
[16] K. Marder,et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.
[17] Christine Klein,et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.
[18] E D Louis,et al. Accuracy of family history data on Parkinson’s disease , 2003, Neurology.
[19] S Wacholder,et al. The kin-cohort study for estimating penetrance. , 1998, American journal of epidemiology.
[20] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.